Selective opioid receptor agonist and antagonist displacement of [ 3 H]naloxone binding in amphibian brain

By Newman L.C.   Wallace D.R.   Stevens C.W.  

European Journal of Pharmacology, Vol. 397, Iss. 2, 2000-06 ,pp. : 255-262

Elsevier

Access to resources Recommend Favorite

The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with - and k-opioid receptor agonists

By Capasso A.   Sorrentino L.   Pinto A.  

European Journal of Pharmacology, Vol. 359, Iss. 2, 1998-10 ,pp. : 127-131

Elsevier

Access to resources Recommend Favorite

Pharmacogenomics of the human µ-opioid receptor

By Kasai Shinya   Ikeda Kazutaka  

Pharmacogenomics, Vol. 12, Iss. 9, 2011-09 ,pp. : 1305-1320

Future Medicine

Access to resources Recommend Favorite

Several -opioid receptor ligands display no subtype selectivity to the human -opioid receptor

By Parkhill A.L.   Bidlack J.M.  

European Journal of Pharmacology, Vol. 451, Iss. 3, 2002-09 ,pp. : 257-264

Elsevier

Access to resources Recommend Favorite

Relative efficacies of -opioid receptor agonists at the cloned human -opioid receptor

By Quock R.M.   Hosohata Y.   Knapp R.J.   Burkey T.H.   Hosohata K.   Zhang X.   Rice K.C.   Nagase H.   Hruby V.J.   Porreca F.   Roeske W.R.   Yamamura H.I.  

European Journal of Pharmacology, Vol. 326, Iss. 1, 1997-05 ,pp. : 101-104

Elsevier

Access to resources Recommend Favorite